BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10669686)

  • 1. The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia.
    Koh YY; Park Y; Jeong JH; Kim CK; Min YG; Chi JG
    Chest; 2000 Feb; 117(2):427-33. PubMed ID: 10669686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
    Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
    Jokic R; Swystun VA; Davis BE; Cockcroft DW
    Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of regular salbutamol on lung function and bronchial hyperresponsiveness in normal subjects and nonasthmatic atopic subjects with allergic rhinitis.
    Boothman-Burrell D; Jones D; Herbison GP; Taylor DR
    Chest; 1997 Jul; 112(1):12-8. PubMed ID: 9228350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
    Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
    Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to beta-agonists during acute bronchoconstriction.
    Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
    Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects.
    Evans DW; Salome CM; King GG; Rimmer SJ; Seale JP; Woolcock AJ
    Thorax; 1997 Feb; 52(2):136-42. PubMed ID: 9059473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids.
    Tormey VJ; Faul J; Leonard C; Lennon A; Burke CM
    Ir J Med Sci; 1997; 166(4):249-52. PubMed ID: 9394077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
    Cockcroft DW; Swystun VA; Bhagat R
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
    Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
    Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular inhaled salbutamol and airway responsiveness to allergen.
    Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
    Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
    Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined lidocaine and salbutamol inhalation for airway anesthesia markedly protects against reflex bronchoconstriction.
    Groeben H; Silvanus MT; Beste M; Peters J
    Chest; 2000 Aug; 118(2):509-15. PubMed ID: 10936148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
    Magnussen H; Willenbrock U; Jörres R
    Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.